The synthesis of a selective PDE4/TNFα inhibitor

被引:34
|
作者
Caron, S [1 ]
Vazquez, E [1 ]
机构
[1] Pfizer Global Res & Dev, Chem Res & Dev, Groton, CT 06340 USA
关键词
D O I
10.1021/op010223p
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Two syntheses of cis-4-cyano-4-(1-cyclohexyl-3-ethyl-1H-indazol-6-yl)cyclohexanecarboxylic acid (1), a selective PDE4/TNF alpha inhibitor are described. The first synthesis relied on a solvolysis of a tertiary benzylic alcohol to the nitrile using TMSCN and on the epimerization of an ester to its thermodynamically favored position prior to its hydrolysis. It was demonstrated that the selectivity was controlled by the rate of hydrolysis of the two diastereomeric esters. The second synthesis proved to be more efficient and used a novel nucleophilic aromatic substitution of a fluoroindazole with the anion of a tertiary nitrile. Another key element of the route was a selective Pinner reaction of a secondary nitrile in the presence of a tertiary nitrile.
引用
收藏
页码:587 / 592
页数:6
相关论文
共 50 条
  • [41] Development of a Practical Process for the Synthesis of PDE4 Inhibitors
    Frutos, Rogelio P.
    Tampone, Thomas G.
    Mulder, Jason A.
    Rodriguez, Sonia
    Yee, Nathan K.
    Yang, Bing-Shiou
    Senanayake, Chris H.
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2016, 20 (05) : 982 - 988
  • [42] Identification of a potent new chemotype for the selective inhibition of PDE4
    Skoumbourdis, Amanda P.
    Huang, Ruili
    Southall, Noel
    Leister, William
    Guo, Vicky
    Cho, Ming-Hsuang
    Inglese, James
    Nirenberg, Marshall
    Austin, Christopher P.
    Xia, Menghang
    Thomas, Craig J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (04) : 1297 - 1303
  • [43] Safety, tolerability and pharmacokinetics of CHF 6001, a novel selective inhaled PDE4 inhibitor, in healthy volunteers
    Lucci, Germano
    Mariotti, Fabrizia
    Santoro, Debora
    Acerbi, Daniela
    Poli, Gianluigi
    Nandeuil, Marie-Anna
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [44] Development of selective heterocyclic PDE4 inhibitors for treatment of psoriasis
    Li, Gang
    He, Dengqin
    Qian, Xudong
    Liu, Yuanhui
    Ou, Yanghui
    Li, Mengjie
    Song, Liyan
    Xu, Zichen
    Zhang, Guoping
    Wang, Jun
    Pan, Wei
    Chen, Jiaxin
    Zhang, Yali
    Wu, Jia-Qiang
    Chen, Dandan
    Chen, Cheng
    Peng, Siying
    Yao, Hongliang
    Ke, Hengming
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 280
  • [45] Characterization of the inflammatory response to a highly selective PDE4 inhibitor in the rat and the identification of biomarkers that correlate with toxicity
    Dietsch, GN
    DiPalma, CR
    Eyre, RJ
    Pham, TQ
    Poole, KM
    Pefaur, NB
    Welch, WD
    Trueblood, E
    Kerns, WD
    Kanaly, ST
    TOXICOLOGIC PATHOLOGY, 2006, 34 (01) : 39 - 51
  • [46] PDE4 inhibitors in COPD - a more selective approach to treatment
    Vignola, AM
    RESPIRATORY MEDICINE, 2004, 98 (06) : 495 - 503
  • [47] Newly synthesized phosphodiesterase 4 (PDE4) inhibitor, DWP205505, inhibits TNF-α secretion and mRNA expression
    Lee, SK
    Lee, SA
    Byun, H
    Cho, ML
    Kim, WU
    Park, SH
    Cho, CS
    Joo, YS
    Lee, SS
    Yoo, ES
    Son, HJ
    Kim, HY
    JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 1999, 9 (01) : 106 - 112
  • [48] Synthesis, biological evaluation and molecular modelling studies on benzothiadiazine derivatives as PDE4 selective inhibitors
    Tait, A
    Luppi, A
    Hatzelmann, A
    Fossa, P
    Mosti, L
    BIOORGANIC & MEDICINAL CHEMISTRY, 2005, 13 (04) : 1393 - 1402
  • [49] Design, Synthesis, and Biological Evaluation of New Selective PDE4 Inhibitors for Topical Treatment of Psoriasis
    He, Dengqin
    Li, Gang
    Wu, Jia-Qiang
    Geng, Yan
    Qian, Xudong
    Liu, Yuanhui
    Ou, Yanghui
    Li, Mengjie
    Wang, Jun
    Pan, Wei
    Zhang, Guoping
    Chen, Dandan
    Chen, Jiaxin
    Xu, Zichen
    Ke, Hengming
    Yao, Hongliang
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (22) : 20353 - 20371
  • [50] Attenuation of TNF production and experimentally induced inflammation by PDE4 inhibitor rolipram is mediated by MAPK phosphatase-1
    Korhonen, Riku
    Hommo, Tuija
    Keranen, Tiina
    Laavola, Mirka
    Hamalainen, Mari
    Vuolteenaho, Katriina
    Lehtimaki, Lauri
    Kankaanranta, Hannu
    Moilanen, Eeva
    BRITISH JOURNAL OF PHARMACOLOGY, 2013, 169 (07) : 1525 - 1536